Citigroup’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.7K Buy
11,049
+2,276
+26% +$2.37K ﹤0.01% 5178
2025
Q4
$8.43K Sell
8,773
-326
-4% -$462 ﹤0.01% 5111
2025
Q3
$15.8K Sell
9,099
-73,438
-89% -$144K ﹤0.01% 4887
2025
Q2
$173K Sell
82,537
-131,706
-61% -$253K ﹤0.01% 4136
2025
Q1
$365K Buy
214,243
+42,377
+25% +$159K ﹤0.01% 3840
2024
Q4
$868K Buy
171,866
+106,249
+162% +$526K ﹤0.01% 3462
2024
Q3
$357K Buy
65,617
+34,196
+109% +$225K ﹤0.01% 3952
2024
Q2
$151K Buy
31,421
+20,690
+193% +$108K ﹤0.01% 4020
2024
Q1
$33.4K Buy
10,731
+154
+1% +$518 ﹤0.01% 4837
2023
Q4
$30K Buy
10,577
+9,262
+704% +$23.8K ﹤0.01% 4806
2023
Q3
$3.85K Sell
1,315
-18,675
-93% -$61.8K ﹤0.01% 4788
2023
Q2
$57.2K Buy
19,990
+18,815
+1,601% +$67.8K ﹤0.01% 4563
2023
Q1
$3.63K Sell
1,175
-2,197
-65% -$6.25K ﹤0.01% 5006
2022
Q4
$7.12K Buy
3,372
+234
+7% +$710 ﹤0.01% 4954
2022
Q3
$10K Sell
3,138
-1,049
-25% -$4.02K ﹤0.01% 4989
2022
Q2
$13K Sell
4,187
-7,672
-65% -$42.7K ﹤0.01% 5232
2022
Q1
$84K Buy
11,859
+7,793
+192% +$45.4K ﹤0.01% 4499
2021
Q4
$29K Buy
4,066
+4
+0.1% +$40 ﹤0.01% 5279
2021
Q3
$47K Buy
+4,062
New +$46.5K ﹤0.01% 4764

Other funds holding HUMA